Editor, Jade Parker recently spoke with George Vassiliou, Group Leader at the Wellcome Trust Sanger Institute (Cambridge, UK) and Honorary Consultant Haematologist at Cambridge University Hospitals (UK).
The Haematological Cancer Genetics team, led by George Vassiliou, studies the genes and genetic pathways involved in the development of blood cancers, with a particular emphasis on acute myeloid leukaemia and related malignancies. The ultimate goal of the team is to help develop treatments that can improve the survival and quality of life of cancer sufferers.
Watch this video to:
Find out how George first became involved in the field of cancer genetics
Discover the hot topics in hematologic oncology research
Uncover the greatest challenges in the field of hematologic oncology research
Learn how the Haematological Cancer Genetics team’s research is uncovering the genetics of blood cancers
To see all the videos in this series of interviews with cancer genomics opinion leaders, subscribe to our Youtube channel!